"Contraceptives, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
| Descriptor ID |
D003276
|
| MeSH Number(s) |
D27.505.696.875.360.276.210 D27.505.954.705.360.276.210
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Contraceptives, Oral".
Below are MeSH descriptors whose meaning is more specific than "Contraceptives, Oral".
This graph shows the total number of publications written about "Contraceptives, Oral" by people in this website by year, and whether "Contraceptives, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 2 | 1 | 3 |
| 1999 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Contraceptives, Oral" by people in Profiles.
-
Types of oral contraceptives and breast cancer survival among women enrolled in Medicaid: A competing-risk model. Maturitas. 2017 Jan; 95:42-49.
-
Reproductive factors and ovarian cancer risk in African-American women. Ann Epidemiol. 2016 09; 26(9):654-62.
-
Cardiovascular disease incidence among females in South Carolina by type of oral contraceptives, 2000-2013: a retrospective cohort study. Arch Gynecol Obstet. 2016 11; 294(5):991-997.
-
Obesity, Oral Contraceptive Use, and Cerebral Venous Thrombosis in Women. JAMA Neurol. 2016 05 01; 73(5):512-3.
-
Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. Am J Epidemiol. 2013 Jun 15; 177(12):1368-77.
-
Predicting oral contraceptive continuation using the transtheoretical model of health behavior change. Perspect Sex Reprod Health. 2011 Mar; 43(1):23-9.
-
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Res Treat. 2010 Feb; 120(1):175-83.
-
Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group. J Clin Oncol. 2008 Mar 20; 26(9):1411-8.
-
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1863-70.
-
Reproductive issues for women with BRCA mutations. J Natl Cancer Inst Monogr. 2005; (34):83-6.